Unveiling the potential: Patient-derived organoids in cancer research and treatment
Patient-derived organoids (PDOs) represent a cutting-edge approach in cancer research that holds significant promise for revolutionizing various aspects of oncology. These three-dimensional structures, cultivated from patient tumor samples, faithfully mimic the intricate cellular composition and arc...
Saved in:
Main Author: | Zhan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024000864 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Organoid development and applications in gynecological cancers: the new stage of tumor treatment
by: Yang Li, et al.
Published: (2025-01-01) -
Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
by: Suya Shen, et al.
Published: (2024-12-01) -
Cholangiocyte organoids for disease, cancer, and regenerative medicine
by: Munemasa Nagao, et al.
Published: (2025-03-01) -
Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
by: David A. Close, et al.
Published: (2025-01-01) -
Organoid models: applications and research advances in colorectal cancer
by: Yijie Wu, et al.
Published: (2025-02-01)